We report a case of bullous erythema multiforme caused by an exotic wood, pao ferro (Machaerium scleroxylon). A 25-year-old female, a luthier (guitar maker) who often handles a variety of woods, developed bullous erythema multiforme. A patch test confirmed a positive reaction to one of the exotic woods, pao ferro. A subsequent accidental short contact with pao ferro 5 months following the first incidence induced a similar exudative erythema. Exotic woods such as pao ferro should be added to the list of contact allergens that can induce bullous erythema multiforme.

Keywords:
Erythema multiforme, Contact allergy, Wood
1.
Fritsch P, Elias P: Erythema multiforme and toxic epidermal necrosis; in Fitzpatrick T, Eisen A, Wolff K, Freedberg I, Austen K (eds): Dermatology in General Medicine. New York, McGraw-Hill, 1993, pp 585–600.
2.
Fisher AA: Erythema multiforme-like eruptions due to exotic woods and ordinary plants. Part I. Cutis 1986;37:101–103.
3.
Fisher AA: Erythema multiforme-like eruptions due to topical medications. Part II. Cutis 1986;37:158–161.
4.
Fisher AA: Erythema multiforme-like eruptions due to topical miscellaneous compounds. Part III. Cutis 1986;37:262–264.
5.
Conde-Salazar L, Garcia Diez A, Rafeensperger F, Hausen BM: Contact allergy to the Brazilian rosewood substitute Machaerium scleroxylon Tul. (pao ferro). Contact Dermatitis 1980;6:246–250.
6.
Wood B: Contact dermatitis from Santos rosewood. Contact Dermatitis 1987;17:249–250.
7.
Morgan JW, Orsler R, Wilkinson D: Dermatitis due to the wood dusts of Khaya anthotheca and Machaerium scleroxylon. Br J Ind Med 1968; 25:119–125.
8.
Chieregato C, Vincenzi C, Guerra L, Rapacchiale S: Occupational airborne contact dermatitis from Machaerium scleroxylon (Santos rosewood). Contact Dermatitis 1993;29:164– 165.
9.
Beck MH, Hausen BM, Dave VK: Allergic contact dermatitis from Machaerium scleroxylum Tul. (pao ferro) in a joinery shop. Clin Exp Dermatol 1984;9:159–166.
10.
Hausen BM: Incidence and significance of toxic and allergic contact dermatitis caused by Machaerium scleroxylum Tul. (pao ferro), a substitute wood for palisander (Dalbergia nigra All.). Hautarzt 1982;33:321–328.
11.
Holst R, Kirby J, Magnusson B: Sensitization to tropical woods giving erythema multiforme-like eruptions. Contact Dermatitis 1976;2:295– 296.
12.
Irvine C, Reynolds A, Finlay AY: Erythema multiforme-like reaction to ‘rosewood’. Contact Dermatitis 1988;19:224–225.
13.
Fisher AA, Bikowski J: Allergic contact dermatitis due to a wooden cross made of Dalbergia nigra. Contact Dermatitis 1981;7:45–46.
14.
Rackett SC, Zug KA: Contact dermatitis to multiple exotic woods. Am J Contact Dermatitis 1997;8:114–117.
15.
O’Donnell B, Tan C: Erythema multiforme reaction to patch testing. Contact Dermatitis 1992;27:230–234.
16.
Whitfeld MJ, Rivers JK: Erythema multiforme after contact dermatitis in response to an epoxy sealant. J Am Acad Dermatol 1991;25:386– 388.
17.
Alomar A, Pujol R, Esquius J: Erythema multiforme-like contact dermatitis. Am J Contact Dermatitis 1990;1:177–179.
18.
Kirby J, Darley C: Erythema multiforme associated with a contact dermatitis to terpenes. Contact Dermatitis 1978;4:238.
19.
Puig L, Alomar A, Randazzo L, Cuatrecasas M: Erythema multiforme-like reaction caused by topical application of Thuja essential oil. Am J Contact Dermatitis 1994;5:94–97.
20.
Schwarz R, Downham T: Erythema multiforme associated with Rhus contact dermatitis. Cutis 1981;27:85–86.
21.
Tosti A, Bardazzi F, Valeri F, Toni F: Erythema multiforme with contact dermatitis to hair dyes. Contact Dermatitis 1987;17:321–322.
22.
Cook LJ: Associated nickel and cobalt contact dermatitis presenting as erythema multiforme. Contact Dermatitis 1982;8:280–281.
23.
Puig L, Fernandez-Figueras MT, Montero MA, Ferrandiz C, Alomar A: Erythema-multiforme-like eruption due to topical contactants: Expression of adhesion molecules and their ligands and characterization of the infiltrate. Contact Dermatitis 1995;33:329–332.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.